Cargando…
Case Report: A Pancreatic Ductal Adenocarcinoma Patient With Concurrent Targetable Somatic Novel KANK1-ALK, UPP2-NTRK3 Fusion, and Pathogenetic Germline BRCA Mutation
Pancreatic ductal adenocarcinoma (PDAC) is presently one of the cancers with the worst survival rates. The current treatment options for PDAC are relatively scarce due to insufficient understanding of molecular characteristics and subtypes of PDAC. Based on next-generation sequencing (NGS), we first...
Autores principales: | Meng, Fan, Lu, Le, Tan, Yuan, Duan, Qianqian, Lu, Hongwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8521337/ https://www.ncbi.nlm.nih.gov/pubmed/34671564 http://dx.doi.org/10.3389/fonc.2021.757965 |
Ejemplares similares
-
KANK1-NTRK3 fusions define a subset of BRAF mutation negative renal metanephric adenomas
por: Catic, Aida, et al.
Publicado: (2020) -
Exceptional Clinical Response to Alectinib in Pancreatic Acinar Cell Carcinoma With a Novel ALK-KANK4 Gene Fusion
por: Gaule, Marina, et al.
Publicado: (2022) -
Genomic Features of Solid Tumor Patients Harboring ALK/ROS1/NTRK Gene Fusions
por: Dai, Yinghuan, et al.
Publicado: (2022) -
Prevalence of conduct disorder in schoolchildren of Kanke
por: Sarkhel, Sujit, et al.
Publicado: (2006) -
Nipple aspiration and ductal lavage in women with a germline BRCA1 or BRCA2 mutation
por: Mitchell, Gillian, et al.
Publicado: (2005)